Dr He on the Evaluation of Camrelizumab Plus Rivoceranib in Unresectable HCC
Aiwu Ruth He, MD, PhD, discusses the evaluation of camrelizumab plus rivoceranib in unresectable hepatocellular carcinoma.
Source: onclive.com
Ct03764293 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ct03764293 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ct03764293 Today - Breaking & Trending Today